持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/11/01 | 3,320 | 3,375 | 3,315 | 3,365 | +55 | +1.7% | 41,500 |
| 2021/10/29 | 3,285 | 3,330 | 3,265 | 3,310 | +25 | +0.8% | 59,600 |
| 2021/10/28 | 3,290 | 3,295 | 3,230 | 3,285 | +5 | +0.2% | 273,800 |
| 2021/10/27 | 3,290 | 3,310 | 3,255 | 3,280 | +20 | +0.6% | 77,400 |
| 2021/10/26 | 3,245 | 3,265 | 3,225 | 3,260 | +50 | +1.6% | 71,800 |
| 2021/10/25 | 3,225 | 3,245 | 3,195 | 3,210 | -60 | -1.8% | 66,800 |
| 2021/10/22 | 3,245 | 3,300 | 3,245 | 3,270 | -5 | -0.2% | 42,400 |
| 2021/10/21 | 3,275 | 3,315 | 3,255 | 3,275 | -10 | -0.3% | 39,600 |
| 2021/10/20 | 3,295 | 3,300 | 3,260 | 3,285 | +30 | +0.9% | 41,600 |
| 2021/10/19 | 3,230 | 3,265 | 3,230 | 3,255 | +5 | +0.2% | 36,200 |
| 2021/10/18 | 3,295 | 3,295 | 3,240 | 3,250 | -55 | -1.7% | 41,400 |
| 2021/10/15 | 3,260 | 3,305 | 3,255 | 3,305 | +50 | +1.5% | 39,800 |
| 2021/10/14 | 3,220 | 3,260 | 3,210 | 3,255 | +5 | +0.2% | 40,600 |
| 2021/10/13 | 3,255 | 3,270 | 3,225 | 3,250 | +10 | +0.3% | 33,500 |
| 2021/10/12 | 3,310 | 3,310 | 3,240 | 3,240 | -85 | -2.6% | 45,000 |
| 2021/10/11 | 3,295 | 3,325 | 3,280 | 3,325 | +20 | +0.6% | 39,700 |
| 2021/10/08 | 3,250 | 3,330 | 3,230 | 3,305 | +55 | +1.7% | 58,900 |
| 2021/10/07 | 3,310 | 3,310 | 3,250 | 3,250 | -40 | -1.2% | 55,700 |
| 2021/10/06 | 3,310 | 3,360 | 3,280 | 3,290 | -20 | -0.6% | 88,400 |
| 2021/10/05 | 3,345 | 3,360 | 3,295 | 3,310 | -55 | -1.6% | 76,200 |
| 2021/10/04 | 3,405 | 3,405 | 3,350 | 3,365 | -15 | -0.4% | 54,000 |
| 2021/10/01 | 3,420 | 3,420 | 3,350 | 3,380 | -40 | -1.2% | 69,600 |
| 2021/09/30 | 3,410 | 3,460 | 3,395 | 3,420 | +20 | +0.6% | 52,300 |
| 2021/09/29 | 3,375 | 3,400 | 3,345 | 3,400 | -50 | -1.4% | 108,000 |
| 2021/09/28 | 3,480 | 3,500 | 3,425 | 3,450 | -25 | -0.7% | 111,100 |
| 2021/09/27 | 3,575 | 3,575 | 3,475 | 3,475 | -100 | -2.8% | 68,600 |
| 2021/09/24 | 3,525 | 3,590 | 3,495 | 3,575 | +120 | +3.5% | 99,300 |
| 2021/09/22 | 3,520 | 3,520 | 3,455 | 3,455 | -95 | -2.7% | 104,300 |
| 2021/09/21 | 3,590 | 3,615 | 3,550 | 3,550 | -75 | -2.1% | 114,900 |
| 2021/09/17 | 3,665 | 3,670 | 3,605 | 3,625 | ±0 | ±0% | 572,900 |
| 2021/09/16 | 3,560 | 3,635 | 3,555 | 3,625 | +60 | +1.7% | 104,900 |
| 2021/09/15 | 3,585 | 3,610 | 3,560 | 3,565 | -75 | -2.1% | 75,000 |
| 2021/09/14 | 3,585 | 3,655 | 3,585 | 3,640 | +30 | +0.8% | 75,100 |
| 2021/09/13 | 3,595 | 3,615 | 3,560 | 3,610 | -10 | -0.3% | 63,400 |
| 2021/09/10 | 3,585 | 3,620 | 3,550 | 3,620 | -15 | -0.4% | 114,800 |
| 2021/09/09 | 3,670 | 3,685 | 3,615 | 3,635 | -60 | -1.6% | 49,100 |
| 2021/09/08 | 3,680 | 3,700 | 3,665 | 3,695 | +35 | +1% | 38,400 |
| 2021/09/07 | 3,700 | 3,700 | 3,645 | 3,660 | +5 | +0.1% | 65,300 |
| 2021/09/06 | 3,640 | 3,670 | 3,610 | 3,655 | +15 | +0.4% | 60,900 |
| 2021/09/03 | 3,600 | 3,685 | 3,585 | 3,640 | +30 | +0.8% | 59,000 |
| 2021/09/02 | 3,635 | 3,635 | 3,585 | 3,610 | -60 | -1.6% | 42,000 |
| 2021/09/01 | 3,660 | 3,670 | 3,635 | 3,670 | +5 | +0.1% | 27,800 |
| 2021/08/31 | 3,600 | 3,695 | 3,590 | 3,665 | +75 | +2.1% | 56,800 |
| 2021/08/30 | 3,590 | 3,610 | 3,565 | 3,590 | +15 | +0.4% | 20,100 |
| 2021/08/27 | 3,555 | 3,595 | 3,550 | 3,575 | +15 | +0.4% | 39,600 |
| 2021/08/26 | 3,610 | 3,610 | 3,560 | 3,560 | -45 | -1.2% | 34,000 |
| 2021/08/25 | 3,620 | 3,630 | 3,580 | 3,605 | -25 | -0.7% | 41,000 |
| 2021/08/24 | 3,595 | 3,630 | 3,580 | 3,630 | -5 | -0.1% | 54,700 |
| 2021/08/23 | 3,565 | 3,650 | 3,560 | 3,635 | +90 | +2.5% | 70,400 |
| 2021/08/20 | 3,570 | 3,590 | 3,525 | 3,545 | ±0 | ±0% | 40,400 |
751～
800
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
